Surgery Partners closed at $23.16 on Nov 4, up 0.13%, 0.9% below its 52-week closing high. Volume of 11.1M shares was 2.00× its 20-day average (above normal).
Split-adjusted performance: +72.7% over one month, +58.7% over six months, +6.7% over one year.
In the quarter ended Jun 30, 2026, revenue was $848.90M, up 2.7% from a year earlier, with a net margin of -1.8%.
Short interest was 14.3M shares at the Oct 15 settlement (18.3% of float, 10.3 days to cover).